# FDA Inspection 1215341 - Cerovene Inc. - August 01, 2023

Source: https://www.keypedia.com/records/fda_inspections/cerovene-inc/bb14bb94-6bdf-4b86-9bd0-0d8ff92ef29d
Source feed: FDA_Inspections

> FDA Inspection 1215341 for Cerovene Inc. on August 01, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1215341
- Company Name: Cerovene Inc.
- Inspection Date: 2023-08-01
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1308838 - 2026-03-23](https://www.keypedia.com/records/fda_inspections/cerovene-inc/05d833d9-e79d-4941-8baa-1d08d52b23af)
- [FDA Inspection 1308838 - 2026-03-23](https://www.keypedia.com/records/fda_inspections/cerovene-inc/ec3e0746-1f62-462a-af07-047cf1e76e33)
- [FDA Inspection 1269142 - 2025-04-28](https://www.keypedia.com/records/fda_inspections/cerovene-inc/ca8c9d19-4154-4d01-97d9-b1defafb20b3)
- [FDA Inspection 1074159 - 2018-11-05](https://www.keypedia.com/records/fda_inspections/cerovene-inc/9f74c709-84da-4852-ac10-55da084f60f1)
- [FDA Inspection 1001439 - 2017-02-08](https://www.keypedia.com/records/fda_inspections/cerovene-inc/afe846b8-4499-4b93-bb15-856205fe84e6)

Company: https://www.keypedia.com/companies/cerovene-inc/f23e944b-ef46-45b3-8177-af154b404c08

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c